Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check4 days agoChange DetectedAbbotsford, British Columbia, Canada, V2T 1X8 entry was reformatted to Abbotsford British Columbia, British Columbia, Canada, V2T 1X8 in the location list.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. There are no visible changes to the Study Details content or its functionality.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2. No visible changes to page content or layout.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded UI elements and metadata: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed the older items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.